Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126772691 | 12677269 | 1 | I | 20160816 | 20160823 | 20160823 | EXP | DE-JNJFOC-20160818334 | JANSSEN | DECAROLIS B, SIMON T, KRUG B, LEUSCHNER I, VOKUHL C, KAATSCH P, ET AL. TREATMENT AND OUTCOME OF GANGLIONEUROMA AND GANGLIONEUROBLASTOMA INTERMIXED. BMC CANCER 27-JUL-2016;16:542:2513-2519. | 0.00 | Y | 0.00000 | 20160823 | OT | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126772691 | 12677269 | 1 | PS | DOXORUBICIN HYDROCHLORIDE. | DOXORUBICIN HYDROCHLORIDE | 1 | Unknown | N | 50718 | LIPOSOME INJECTION | |||||||||
| 126772691 | 12677269 | 2 | SS | CISPLATIN. | CISPLATIN | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126772691 | 12677269 | 3 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126772691 | 12677269 | 4 | SS | VINDESINE | VINDESINE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 126772691 | 12677269 | 5 | SS | VINCRISTINE | VINCRISTINE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126772691 | 12677269 | 6 | SS | DACARBAZINE. | DACARBAZINE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126772691 | 12677269 | 7 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126772691 | 12677269 | 1 | Ganglioneuroblastoma |
| 126772691 | 12677269 | 2 | Ganglioneuroblastoma |
| 126772691 | 12677269 | 3 | Ganglioneuroblastoma |
| 126772691 | 12677269 | 4 | Ganglioneuroblastoma |
| 126772691 | 12677269 | 5 | Ganglioneuroblastoma |
| 126772691 | 12677269 | 6 | Ganglioneuroblastoma |
| 126772691 | 12677269 | 7 | Ganglioneuroblastoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126772691 | 12677269 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126772691 | 12677269 | Cardiac failure | |
| 126772691 | 12677269 | Off label use | |
| 126772691 | 12677269 | Product use issue | |
| 126772691 | 12677269 | Pulmonary oedema |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |